Literature DB >> 31330407

Striatal morphology and neurocognitive dysfunction in Huntington disease: The IMAGE-HD study.

Fiona A Wilkes1, Zvart Abaryan2, Chris R K Ching2, Boris A Gutman3, Sarah K Madsen2, Mark Walterfang4, Dennis Velakoulis5, Julie C Stout6, Phyllis Chua7, Gary F Egan8, Paul M Thompson9, Jeffrey C L Looi10, Nellie Georgiou-Karistianis6.   

Abstract

We aimed to investigate the relationship between striatal morphology in Huntington disease (HD) and measures of motor and cognitive dysfunction. MRI scans, from the IMAGE-HD study, were obtained from 36 individuals with pre-symptomatic HD (pre-HD), 37 with early symptomatic HD (symp-HD), and 36 healthy matched controls. The neostriatum was manually segmented and a surface-based parametric mapping protocol derived two pointwise shape measures: thickness and surface dilation ratio. Significant shape differences were detected between all groups. Negative associations were detected between lower thickness and surface area shape measure and CAG repeats, disease burden score, and UHDRS total motor score. In symp-HD, UPSIT scores were correlated with higher thickness in left caudate tail and surface dilation ratio in left posterior putamen; Stroop scores were positively correlated with the thickness of left putamen head and body. Self-paced tapping (slow) was correlated with higher thickness and surface dilation ratio in the right caudate in symp-HD and with bilateral putamen in pre-HD. Self-paced tapping (fast) was correlated with higher surface dilation ratio in the right anterior putamen in symp-HD. Shape changes correlated with functional measures subserved by corticostriatal circuits, suggesting that the neostriatum is a potentially useful structural basis for characterisation of endophenotypes of HD.
Copyright © 2019. Published by Elsevier B.V.

Entities:  

Keywords:  Biomarker Huntington disease; Endophenotype; Neostriatum

Mesh:

Year:  2019        PMID: 31330407     DOI: 10.1016/j.pscychresns.2019.07.003

Source DB:  PubMed          Journal:  Psychiatry Res Neuroimaging        ISSN: 0925-4927            Impact factor:   2.376


  2 in total

Review 1.  The presymptomatic phase of amyotrophic lateral sclerosis: are we merely scratching the surface?

Authors:  Rangariroyashe H Chipika; We Fong Siah; Mary Clare McKenna; Stacey Li Hi Shing; Orla Hardiman; Peter Bede
Journal:  J Neurol       Date:  2020-10-31       Impact factor: 6.682

2.  Rate of torque development and striatal shape in individuals with prodromal Huntington's disease.

Authors:  Travis Cruickshank; Alvaro Reyes; Timothy S Pulverenti; Tim Rankin; Danielle M Bartlett; Anthony J Blazevich; Govinda Poudel; Mel Ziman; Gabriel S Trajano
Journal:  Sci Rep       Date:  2020-09-15       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.